Target intelligence / Profile preview

Mycobacterium tuberculosis cell wall synthesis pathway

Molecular classification
Enzyme, Biosynthetic pathway, Other (supramolecular complex)
01

Overview

The *Mycobacterium tuberculosis* cell wall synthesis pathway comprises numerous enzymes responsible for assembling a unique, lipid-rich, multi-layered envelope. This cell wall is made up of three main components: a peptidoglycan layer, an arabinogalactan polysaccharide, and a mycolic acid outer layer, with additional complex glycolipids and free lipids[2][3][4][6][7]. The cell wall’s structure furnishes *M. tuberculosis* with resilience to environmental stresses, resistance to both host immunity and antibiotics, and is directly implicated in the organism’s virulence and persistence. Because of its essential role in bacterial survival and pathogenesis, enzymes and processes in this pathway are the most widely exploited targets for both first-line and novel anti-tuberculosis drugs. However, drug resistance and challenges in drug delivery due to the impermeable barrier remain major obstacles to effective therapy[4][3][7].

Other names
Mtb cell envelope biosynthesisMycobacterial cell wall biogenesisMycobacterium tuberculosis cell wall assemblyMtb cell wall synthesis
02

Mechanism of action

Inhibition of mycolic acid synthesis; Inhibition of arabinogalactan synthesis; Inhibition of peptidoglycan synthesis; Disruption of cell wall assembly

03

Biological functions

Cell envelope biosynthesisStructural integrityMaintenance of virulenceAntibiotic resistanceImmune evasion
04

Disease associations

Infection (tuberculosis; critical for pathogenesis and virulence)Antibiotic resistance (enables multidrug resistance)
05

Safety considerations

Drug resistance developmentToxicities associated with prolonged multi-drug regimens (e.g., hepatotoxicity, neurotoxicity, hypersensitivity)Limited permeability of cell wall can compromise treatment efficacy and promote persistence
06

Interacting drugs

Isoniazid (INH)

10 more in the full profile.

07

Biomarkers

Mycolic acid levels (for efficacy)Lipoarabinomannan (LAM, for detection/diagnosis)

Beyond the preview

Go deeper on Mycobacterium tuberculosis cell wall synthesis pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterium tuberculosis cell wall synthesis pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call